Regulation of Glucose Uptake in Mesangial Cells Stimulated by High Glucose: Role of Angiotensin II and Insulin

Mesangial cells (MCs) play a central role in the pathogenesis of diabetic nephropathy (DN). MC dysfunction arises from excessive glucose uptake through insulin-independent glucose transporter (GLUT1). The role of the insulin-dependent transporter (GLUT4) remains unknown. This study evaluated the effect of high glucose on GLUT1, GLUT4, and fibronectin expression levels. Glucose uptake was determined in the absence and presence of insulin. Angiotensin II has been implicated as a mediator of MC abnormalities in DN, and its effects on the GLUTs expression were evaluated in the presence of losartan. MCs were exposed to normal (NG, 10 mM) or high (HG, 30 mM) glucose for 1, 4, 12, 24, and 72 hrs. Glucose uptake was elevated from 1 hr up to 24 hrs of HG, but returned to NG levels after 72 hrs. HG induced an early (1-, 4-, and 12-hrs) rise in GLUT1 expression, returning to NG levels after 72 hrs, whereas GLUT4 was overexpressed at later timepoints (24 and 72 hrs). HG during 4 hrs induced a 40% rise in glucose uptake, which was unaffected by insulin. In contrast, after 72 hrs, glucose uptake was increased by 50%, only under insulin stimulus. Losartan blunted the effects of HG on GLUT1, GLUT4, and fibronectin expression and on glucose uptake. Results suggest that MCs can be highly susceptible to the HG environment since they uptake glucose in both an insulin-independent and insulin-dependent manner. The beneficial effects of angiotensin II inhibition in DN may also involve a decrease in the rate of glucose uptake by MCs.

[1]  M. Kretzler,et al.  From Fibrosis to Sclerosis , 2008, Diabetes.

[2]  D. Casarini,et al.  High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. , 2004, American journal of physiology. Renal physiology.

[3]  H. Eldar-Finkelman,et al.  Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[4]  Ashutosh Kumar Singh,et al.  J Am Soc Nephrol 14: 873–880, 2003 Mechanism of Increased Angiotensin II Levels in Glomerular , 2022 .

[5]  E. Schleicher,et al.  Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. , 2003, Diabetes.

[6]  R. Loberg,et al.  Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. , 2001, American journal of physiology. Renal physiology.

[7]  N. Hollenberg,et al.  The paradox of the low-renin state in diabetic nephropathy. , 1999, Journal of the American Society of Nephrology : JASN.

[8]  J. Busik,et al.  Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT1 in mesangial cells in vitro. , 1999, The American journal of physiology.

[9]  J. Busik,et al.  Glucose transporters control gene expression of aldose reductase, PKCα, and GLUT1 in mesangial cells in vitro. , 1999, American journal of physiology. Renal physiology.

[10]  K. Inoki,et al.  TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. , 1999, Kidney international.

[11]  D. Casarini,et al.  Purification and characterization of angiotensin I‐converting enzymes from mesangial cells in culture , 1998, Journal of hypertension.

[12]  W. Mccumbee,et al.  Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells , 1998, Journal of cellular physiology.

[13]  K. Sharma,et al.  Potential Role of TGF-β in Diabetic Nephropathy , 1998, Mineral and Electrolyte Metabolism.

[14]  R.C. Harris,et al.  Mechanical Stretch/Relaxation Stimulates a Cellular Renin-Angiotensin System in Cultured Rat Mesangial Cells , 1998, Nephron Experimental Nephrology.

[15]  S. Freytag,et al.  D-Glucose Stimulates Mesangial Cell GLUT1 Expression and Basal and IGF-I–Sensitive Glucose Uptake in Rat Mesangial Cells: Implications for Diabetic Nephropathy , 1997, Diabetes.

[16]  U. Sauer,et al.  High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan. , 1996, The American journal of physiology.

[17]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[18]  S. Freytag,et al.  Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. , 1995, The Journal of clinical investigation.

[19]  N. Schor,et al.  FK 506: effects on glomerular hemodynamics and on mesangial cells in culture. , 1995, Kidney international.

[20]  R. Spiro,et al.  Glucose entry into rat mesangial cells is mediated by both Na+-coupled and facilitative transporters , 1995, Diabetologia.

[21]  M. Haneda,et al.  The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats. , 1994, Diabetes research and clinical practice.

[22]  N. Perico,et al.  Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. , 1993, Journal of the American Society of Nephrology : JASN.

[23]  B. C. Low,et al.  Angiotensin II stimulates glucose transport activity in cultured vascular smooth muscle cells. , 1992, The Journal of biological chemistry.

[24]  B. Chavers,et al.  Mesangial Expansion as a Central Mechanism for Loss of Kidney Function in Diabetic Patients , 1989, Diabetes.

[25]  G. Camussi,et al.  Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. , 2005, Current diabetes reviews.

[26]  Y. Mori,et al.  Regulation of glucose transporter (GLUT1) gene expression by angiotensin II in mesangial cells: involvement of HB-EGF and EGF receptor transactivation. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[27]  K. Sharma,et al.  Potential role of TGF-beta in diabetic nephropathy. , 1998, Mineral and electrolyte metabolism.

[28]  C. Nast,et al.  Expression of transforming growth factor-beta isoforms in human glomerular diseases. , 1996, Kidney international.